CONCLUSION
In instances of this nature, the individual is required to undergo a series of procedures and investigations. The evaluation process relies on the individual’s medical history, which, in this instance, is not significant. The rarity of this case is attributed to the presence of significant pulmonary hypertension characterized by a pulmonary artery diameter measuring 38mm and the additional active hemoptysis, which necessitated a delay in performing bronchoscopy due to the potential risk of bleeding. Despite being a well-acknowledged therapeutic technique for patients experiencing severe recurrent hemoptysis and providing prompt control of bleeding, embolotherapy still carries a notable risk of re-bleeding. In the current context, the heightened severity of the illness may lead to exacerbated long-term complications when surgical intervention is employed, due to the patient’s atypical anatomical variation of the PDA in relation to the aorta as well as the severity of the symptoms presented. Furthermore, this particular instance serves as a cautionary tale for medical professionals to exercise vigilant monitoring of patients presenting with identical symptoms and displaying signs of pulmonary hypertension.